UBS Group’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,482
| Closed | -$2K | – | 8518 |
|
|
2019
Q2 | $2K | Buy |
+1,482
| New | +$1.7K | ﹤0.01% | 7685 |
|
|
2019
Q1 | – | Sell |
-10,868
| Closed | -$11K | – | 8485 |
|
|
2018
Q4 | $11K | Buy |
+10,868
| New | +$10.9K | ﹤0.01% | 7216 |
|
|
2018
Q3 | – | Sell |
-153
| Closed | – | – | 8478 |
|
|
2018
Q2 | $0 | Sell |
153
-912
| -86% | -$1.24K | ﹤0.01% | 8443 |
|
|
2018
Q1 | $1K | Buy |
1,065
+15
| +1% | +$21 | ﹤0.01% | 7715 |
|
|
2017
Q4 | $1K | Buy |
+1,050
| New | +$1.26K | ﹤0.01% | 7766 |
|
|
2017
Q3 | – | Sell |
-8,484
| Closed | -$8K | – | 8172 |
|
|
2017
Q2 | $8K | Buy |
+8,484
| New | +$7.42K | ﹤0.01% | 6946 |
|
|
2017
Q1 | – | Sell |
-2,855
| Closed | -$3K | – | 8196 |
|
|
2016
Q4 | $3K | Buy |
+2,855
| New | +$2.81K | ﹤0.01% | 7456 |
|
|
2016
Q2 | – | Sell |
-4,395
| Closed | -$12K | – | 8123 |
|
|
2016
Q1 | $12K | Sell |
4,395
-1,798
| -29% | -$4.05K | ﹤0.01% | 6562 |
|
|
2015
Q4 | $14K | Buy |
6,193
+402
| +7% | +$841 | ﹤0.01% | 7100 |
|
|
2015
Q3 | $11K | Buy |
5,791
+3,984
| +220% | +$8.34K | ﹤0.01% | 7226 |
|
|
2015
Q2 | $4K | Buy |
1,807
+807
| +81% | +$1.49K | ﹤0.01% | 8014 |
|
|
2015
Q1 | $2K | Sell |
1,000
-5,319
| -84% | -$9.07K | ﹤0.01% | 8487 |
|
|
2014
Q4 | $12K | Buy |
+6,319
| New | +$13.4K | ﹤0.01% | 8267 |
|
UBS Group's IMI Position: Q3 2019 in Review
UBS Group sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 1,482 shares — an estimated $2K sold.
UBS Group first reported a position in IMI in Q4 2014 and held it in 13 quarters. The position peaked at $14K in Q4 2015. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.
- UBS Group reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
- UBS Group sold 1,482 Intermolecular, Inc. shares in Q3 2019, an estimated $2K.
- UBS Group first reported a position in Intermolecular, Inc. in Q4 2014 and held it in 13 quarters.
- UBS Group's Intermolecular, Inc. position peaked at $14K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.
Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.